Navigation Links
Personalized molecular therapy shows promising results for people with advanced lung cancer
Date:12/9/2010

A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and The University of Chicago.

Epigenetics therapy is an approach designed to control the expression of good and bad genes that influence the development of resistance to targeted therapies. This study, called ENCORE 401, was designed to evaluate whether entinostat, a novel epigenetic therapy that is given orally, can be used to delay or overcome the resistance to erlotinib in patients with advanced lung cancer.

This study was a randomized phase II placebo controlled clinical trial in advanced lung cancer examining whether entinostat in combination with erlotinib is better than erlotinib alone and whether it can be safely tolerated by patients. As part of the clinical trial, patients underwent an analysis of various tissue and blood biomarkers. The results demonstrated that patients with elevated E-cadherin (a molecular marker) who were administered entinostat in combination with erlotinib had a significantly improved overall survival as compared to patients treated with erlotinib alone. Approximately 40 percent of non-small cell lung cancer patients have elevated E-cadherin.

These findings highlight the importance of patient selection in defining treatment approaches in lung cancer and, if confirmed, could provide benefit to patients who have or develop resistance to current molecular targeted therapy.

"The results of ENCORE 401 identified a subset of lung cancer patients for whom the combination of epigenetic therapy, entinostat and molecular targeted therapy, erlotinib, achieved promising result
'/>"/>

Contact: Beth Bukata
bethb@astro.org
703-431-2332
American Society for Radiation Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
2. Personalized medicine: Tumor analysis reveals new opportunities for existing cancer drugs
3. New venture explores frontiers of personalized medicine
4. Personalized treatment may help some liver cancer patients
5. Perspectives on improving patient care: Genetics, personalized medicine, and behavioral intervention
6. Penn receives $12 million NIH grant to research personalized approach to smoking cessation
7. Personalized medicine: Molecular imaging predicts treatment success in many cancers
8. Pilot study supports adolescent diabetes patients through personalized text messages
9. Tumor target suggests personalized treatment for melanoma
10. Advances in personalized medicine take center stage
11. Myth Debunked: Baby Shower Gifts CAN Be Personalized Without Knowing Name Or Gender
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Angeles, CA (PRWEB) October 01, 2014 ... power score of 3.1 out of 5, which ... users include food and beverage manufacturers, food service ... As a result of these users' diversity, demand ... As such, rising industrial production, consumer spending and ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 To help raise ... center , Cutler Integrative Medicine, is detailing several tips for ... , According to Dr. Cutler, women should start each ... time for yourself that will help ‘center’ yourself for the ... stress,” he says. , Other health and fitness tips ...
(Date:10/1/2014)... CO (PRWEB) October 01, 2014 Nearly ... after a Pueblo County District Court jury awarded him ... cancer at 61 years old. Casper had been ... , According to the Court Documents (District ... treated for BPH, a benign non-cancerous condition of his ...
(Date:9/30/2014)... be proactive about potential disease outbreaks like Ebola and ... an Editorial in the October issue of Australian ... Cheng from Monash University and Heath Kelly from the ... crises. , "Australia would do well to heed the ... co-ordinating a consistent and outward looking response," the authors ...
(Date:9/30/2014)... (HealthDay News) -- There,s no genetic evidence that high ... a new study says. Some previous research had ... people against type 2 diabetes, raising the possibility of ... sugar disease. In this study, British researchers investigated ... focusing on genes that control blood levels of vitamin ...
Breaking Medicine News(10 mins):Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 4Health News:In Recognition of National Women’s Health and Fitness Day, Cutler Integrative Medicine Details Tips for Living a Healthier and Happier Life 2Health News:Law Offices of D.R. Jones Client Wins 4.7 Million Dollar Verdict, Insurance Company Files Motion for a New Trial 2Health News:Law Offices of D.R. Jones Client Wins 4.7 Million Dollar Verdict, Insurance Company Files Motion for a New Trial 3Health News:Gene Study Finds No Proof Vitamin D Guards Against Type 2 Diabetes 2
... -- Racism is similar to trauma in how it ... United States, a new analysis finds. An examination ... black adults concluded that there are common responses to ... is expressed as physical pain), interpersonal sensitivity and anxiety. ...
... Nov. 24 (HealthDay News) -- Black Friday, the kickoff to ... as it is about getting good deals, according to a ... Friday adventure phenomenon, the more fun you,re likely to add ... Wake Forest University, said in a university news release. ...
... -- A 36-year-old husband and father of two children with ... world,s first artificial trachea made with stem cells. ... described the transplant surgery, which was performed in June ... the transplant, the authors of the report explained, the man ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, ... Americans are hospitalized for adverse drug reactions yearly, and ... a new study finds. The four types of ... -- account for two-thirds of those drug-related emergency hospitalizations. ...
... that treats Type-2 diabetes has been shown to prevent ... the growth of breast cancer cells, according to a ... The research, led by pediatrics professor James Trosko ... biological evidence for previously reported epidemiological surveys that long-term ...
... , WEDNESDAY, Nov. 23 (HealthDay News) -- Preschoolers who ... are often prescribed inhaled steroid medication, and new research ... as-needed basis instead of every day. Respiratory ... and the treatment for some of these kids -- ...
Cached Medicine News:Health News:1st Artificial Windpipe Made With Stem Cells Seems Successful 2Health News:Four Common Meds Send Thousands of Seniors to Hospital: CDC 2Health News:Four Common Meds Send Thousands of Seniors to Hospital: CDC 3Health News:Diabetes drug shows promise in reducing risk of cancer 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 3
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
(Date:9/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ), today announced ... Executive Officer, will preside over the NASDAQ Stock Market ... of Breast Cancer Awareness Month. In his remarks, Mr. ... important benefits of Hologic,s 3D Mammography technology, the only ... to traditional mammography. This is the ninth ...
(Date:9/30/2014)... , Sept. 30, 2014 Arbor Pharmaceuticals, ... Summary Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. ... overview of the Arbor Pharmaceuticals, LLC.,s pharmaceutical research ... information on the current therapeutic developmental pipeline of ... various stages, therapeutics assessment by drug target, mechanism ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3
... 2011 Volcano Corporation (NASDAQ: VOLC ), ... and therapy guidance tools designed to enhance the treatment ... it will be participating in the Tenth Annual JMP ... The presentation by John Dahldorf, chief financial officer, will ...
... May 2, 2011 SeraCare Life Sciences announced today ... of the National Institutes of Health has awarded a ... expired on April 30, 2011. Under this contract, SeraCare, ... proper collection, processing and storage for biorepository collections. SeraCare ...
Cached Medicine Technology:SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research 2SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research 3
... The National Laboratory Training Network (NLTN) ... Association of Public Health Laboratories (APHL) and ... (CDC). NLTN provides cost-effective training in a ... resources, including a FREE Lending Library. Log ...
... The AAFP-PT Laboratory Proficiency Testing and ... programs are designed to assist POLs, clinics ... are designed to assure accuracy of patient ... regulatory requirements. Participation provides the opportunity to ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
Medicine Products: